Mental Health

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Digital Health Market Is Projected to Reach US$ 1921.38 Billion By 2031 With CAGR Of 25.7% | The Insight Partners

NEW YORK, Sept. 17, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global digital...

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

BOSTON, Sept. 17, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science...

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Over 5 million New York Medicaid members to gain access to Transcranial Magnetic Stimulation (TMS) servicesMALVERN, Pa., Sept. 17, 2025...

Connected Health Market is Projected To Reach US$421.5 Billion By 2031 With CAGR of 6.5% During 2025-2031 | The Insight Partners

NEW YORK, Sept. 16, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global connected...

Promising New Preclinical Therapy Offers Hope in the Development of Precision Medicine Treatments for Aggressive Cancers

Children's Hospital of Philadelphia Researchers Find New Therapies Show Promise Against ALK-Driven Cancers PHILADELPHIA, Sept. 16, 2025 /PRNewswire/ -- Researchers...

error: Content is protected !!